Advertisement

NLS antaros medical

Financing - January 4, 2017

Antaros Medical and Almi Invest adds 3 MSEK to Emeriti Pharma

Emeriti Pharma, which is developing a new treatment for skin diseases, takes up two million in venture capital from Antaros Medical. The existing owner, Almi Invest, is also participating in the funding, which has a total value of three million SEK. Emeriti Pharma also announces that the company is currently conducting a Phase 1 study […]

Collaboration - May 31, 2016

Antaros in collaboration with Sahlgrenska and AstraZeneca

Antaros Medical, Sahlgrenska University Hospital and AstraZeneca have announced a kidney imaging collaboration aiming to develop new tools to treat chronic kidney disease (CKD). The collaboration partners will work together on a study to examine a range of imaging endpoints in patients with CKD. The aim is to determine which imaging biomarkers are best suited to follow CKD progression […]

In a new job - May 4, 2016

New R&D Director at Antaros Medical

Antaros Medical has  appointed Carl Sjöberg as the Director R&D Imaging. Carl Sjöberg, MSc, is a widely experienced software developer with background within physics engineering and medical physics, and is now joining Antaros Medical CoreLab in Uppsala. In this strategically important role, Carl will further strengthen Antaros unique portfolio of innovative MRI/PET techniques and also further develop […]

In a new job - January 28, 2016

Antaros Medical makes key appointments

Antaros Medical, a service provider in drug development using imaging, has made two key appointments, Klas Malmberg, as the Chief Medical Officer and Elisabeth Bolling-Sternevald, as the Chief Operating Officer. Klas Malmberg MD, PhD, FESC, is an experienced cardiologist, medical expert and senior lecturer with wide experience from both academic and pharmaceutical industry. Klas extensive merit list […]

Collaboration - January 15, 2016

Antaros Medical supports SANOFI research in incretin biology

Antaros Medical, has entered into a research agreement with  SANOFI. The project seeks to increase the understanding of the activity of certain incretins and underscores the vital role Antaros Medical plays as a trusted partner to major drug manufacturers. “The Antaros team has an impressive track record in early clinical experimentation and clinical functional imaging. […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.